{"id":6719,"date":"2012-12-10T15:31:05","date_gmt":"2012-12-10T14:31:05","guid":{"rendered":"https:\/\/www.microchirurgiaoculare.com\/?p=6719"},"modified":"2018-09-04T16:18:06","modified_gmt":"2018-09-04T14:18:06","slug":"maculopathy-hope-from-a-new-therapy","status":"publish","type":"post","link":"https:\/\/www.microchirurgiaoculare.com\/en\/news-en\/maculopathy-hope-from-a-new-therapy\/","title":{"rendered":"Maculopathy: hope from a new therapy"},"content":{"rendered":"<p>The latest medication for maculopathy&#8217;s cure is based on Aflibercept and is approved for use in Europe on 27 November 2012.<\/p>\n<p>The medicine is administered with intravitreal injection and has the advantage to stop VEGF-A and PIGF. The blockage of PIGF (placental growth factor) is an important innovation for the cure of exudative maculopathy.<\/p>\n<p>Moreover, using this drug, the intravitreal injection can be reduced. In USA, Aflibercept was approved even for the treatment of macular edema caused by retina\u2019s central vein\u2019s thrombosis.<\/p>\n<p><!--:--><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The latest medication for maculopathy&#8217;s cure is based on Aflibercept and is approved for use in Europe on 27 November 2012. The medicine is administered with intravitreal injection and has the advantage to stop VEGF-A and PIGF. The blockage of PIGF (placental growth factor) is an important innovation for the cure of exudative maculopathy. Moreover, [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":10919,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":"","_members_access_role":[],"_members_access_error":""},"categories":[92],"tags":[146,106,149,95,109,153],"class_list":["post-6719","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-en-news","tag-cure-maculopathy","tag-exudative-maculopathy","tag-intravitreal-injection","tag-maculopathy","tag-maculopathy-therapy","tag-maculopathy-treatment"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Maculopathy: hope from a new therapy<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.microchirurgiaoculare.com\/en\/news-en\/maculopathy-hope-from-a-new-therapy\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Maculopathy: hope from a new therapy\" \/>\n<meta property=\"og:description\" content=\"The latest medication for maculopathy&#8217;s cure is based on Aflibercept and is approved for use in Europe on 27 November 2012. The medicine is administered with intravitreal injection and has the advantage to stop VEGF-A and PIGF. The blockage of PIGF (placental growth factor) is an important innovation for the cure of exudative maculopathy. Moreover, [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.microchirurgiaoculare.com\/en\/news-en\/maculopathy-hope-from-a-new-therapy\/\" \/>\n<meta property=\"og:site_name\" content=\"VistaClinic\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/vistaclinicitaly\" \/>\n<meta property=\"article:published_time\" content=\"2012-12-10T14:31:05+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2018-09-04T14:18:06+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.microchirurgiaoculare.com\/wp-content\/uploads\/2018\/09\/ivt.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"220\" \/>\n\t<meta property=\"og:image:height\" content=\"229\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"translator\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Maculopathy: hope from a new therapy","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.microchirurgiaoculare.com\/en\/news-en\/maculopathy-hope-from-a-new-therapy\/","og_locale":"en_US","og_type":"article","og_title":"Maculopathy: hope from a new therapy","og_description":"The latest medication for maculopathy&#8217;s cure is based on Aflibercept and is approved for use in Europe on 27 November 2012. The medicine is administered with intravitreal injection and has the advantage to stop VEGF-A and PIGF. The blockage of PIGF (placental growth factor) is an important innovation for the cure of exudative maculopathy. Moreover, [&hellip;]","og_url":"https:\/\/www.microchirurgiaoculare.com\/en\/news-en\/maculopathy-hope-from-a-new-therapy\/","og_site_name":"VistaClinic","article_publisher":"https:\/\/www.facebook.com\/vistaclinicitaly","article_published_time":"2012-12-10T14:31:05+00:00","article_modified_time":"2018-09-04T14:18:06+00:00","og_image":[{"width":220,"height":229,"url":"https:\/\/www.microchirurgiaoculare.com\/wp-content\/uploads\/2018\/09\/ivt.jpg","type":"image\/jpeg"}],"author":"translator","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.microchirurgiaoculare.com\/en\/news-en\/maculopathy-hope-from-a-new-therapy\/#article","isPartOf":{"@id":"https:\/\/www.microchirurgiaoculare.com\/en\/news-en\/maculopathy-hope-from-a-new-therapy\/"},"author":{"name":"translator","@id":"https:\/\/www.microchirurgiaoculare.com\/en\/#\/schema\/person\/1eb49c806cfaa801607c7afd4ad58326"},"headline":"Maculopathy: hope from a new therapy","datePublished":"2012-12-10T14:31:05+00:00","dateModified":"2018-09-04T14:18:06+00:00","mainEntityOfPage":{"@id":"https:\/\/www.microchirurgiaoculare.com\/en\/news-en\/maculopathy-hope-from-a-new-therapy\/"},"wordCount":89,"publisher":{"@id":"https:\/\/www.microchirurgiaoculare.com\/en\/#organization"},"image":{"@id":"https:\/\/www.microchirurgiaoculare.com\/en\/news-en\/maculopathy-hope-from-a-new-therapy\/#primaryimage"},"thumbnailUrl":"https:\/\/www.microchirurgiaoculare.com\/wp-content\/uploads\/2018\/09\/ivt.jpg","keywords":["cure maculopathy","exudative maculopathy","intravitreal injection","maculopathy","maculopathy therapy","maculopathy treatment"],"articleSection":["News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.microchirurgiaoculare.com\/en\/news-en\/maculopathy-hope-from-a-new-therapy\/","url":"https:\/\/www.microchirurgiaoculare.com\/en\/news-en\/maculopathy-hope-from-a-new-therapy\/","name":"Maculopathy: hope from a new therapy","isPartOf":{"@id":"https:\/\/www.microchirurgiaoculare.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.microchirurgiaoculare.com\/en\/news-en\/maculopathy-hope-from-a-new-therapy\/#primaryimage"},"image":{"@id":"https:\/\/www.microchirurgiaoculare.com\/en\/news-en\/maculopathy-hope-from-a-new-therapy\/#primaryimage"},"thumbnailUrl":"https:\/\/www.microchirurgiaoculare.com\/wp-content\/uploads\/2018\/09\/ivt.jpg","datePublished":"2012-12-10T14:31:05+00:00","dateModified":"2018-09-04T14:18:06+00:00","breadcrumb":{"@id":"https:\/\/www.microchirurgiaoculare.com\/en\/news-en\/maculopathy-hope-from-a-new-therapy\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.microchirurgiaoculare.com\/en\/news-en\/maculopathy-hope-from-a-new-therapy\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.microchirurgiaoculare.com\/en\/news-en\/maculopathy-hope-from-a-new-therapy\/#primaryimage","url":"https:\/\/www.microchirurgiaoculare.com\/wp-content\/uploads\/2018\/09\/ivt.jpg","contentUrl":"https:\/\/www.microchirurgiaoculare.com\/wp-content\/uploads\/2018\/09\/ivt.jpg","width":220,"height":229},{"@type":"BreadcrumbList","@id":"https:\/\/www.microchirurgiaoculare.com\/en\/news-en\/maculopathy-hope-from-a-new-therapy\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.microchirurgiaoculare.com\/en\/home\/"},{"@type":"ListItem","position":2,"name":"Maculopathy: hope from a new therapy"}]},{"@type":"WebSite","@id":"https:\/\/www.microchirurgiaoculare.com\/en\/#website","url":"https:\/\/www.microchirurgiaoculare.com\/en\/","name":"VistaClinic","description":"Dr. Federico Badal\u00e0","publisher":{"@id":"https:\/\/www.microchirurgiaoculare.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.microchirurgiaoculare.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.microchirurgiaoculare.com\/en\/#organization","name":"VistaClinic - Dott. Federico Badal\u00e0","alternateName":"VistaClinic","url":"https:\/\/www.microchirurgiaoculare.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.microchirurgiaoculare.com\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.microchirurgiaoculare.com\/wp-content\/uploads\/2026\/07\/vistaclinic-fav.png","contentUrl":"https:\/\/www.microchirurgiaoculare.com\/wp-content\/uploads\/2026\/07\/vistaclinic-fav.png","width":512,"height":512,"caption":"VistaClinic - Dott. Federico Badal\u00e0"},"image":{"@id":"https:\/\/www.microchirurgiaoculare.com\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/vistaclinicitaly","https:\/\/www.youtube.com\/@VistaClinic_italy","https:\/\/www.instagram.com\/vistaclinic_italy\/"]},{"@type":"Person","@id":"https:\/\/www.microchirurgiaoculare.com\/en\/#\/schema\/person\/1eb49c806cfaa801607c7afd4ad58326","name":"translator","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/4c9dfe97295bfb8278f3098694144a813061fa91ee75b01bd99f64eb9e791232?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/4c9dfe97295bfb8278f3098694144a813061fa91ee75b01bd99f64eb9e791232?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/4c9dfe97295bfb8278f3098694144a813061fa91ee75b01bd99f64eb9e791232?s=96&d=mm&r=g","caption":"translator"}}]}},"_links":{"self":[{"href":"https:\/\/www.microchirurgiaoculare.com\/en\/wp-json\/wp\/v2\/posts\/6719","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.microchirurgiaoculare.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.microchirurgiaoculare.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.microchirurgiaoculare.com\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.microchirurgiaoculare.com\/en\/wp-json\/wp\/v2\/comments?post=6719"}],"version-history":[{"count":0,"href":"https:\/\/www.microchirurgiaoculare.com\/en\/wp-json\/wp\/v2\/posts\/6719\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.microchirurgiaoculare.com\/en\/wp-json\/wp\/v2\/media\/10919"}],"wp:attachment":[{"href":"https:\/\/www.microchirurgiaoculare.com\/en\/wp-json\/wp\/v2\/media?parent=6719"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.microchirurgiaoculare.com\/en\/wp-json\/wp\/v2\/categories?post=6719"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.microchirurgiaoculare.com\/en\/wp-json\/wp\/v2\/tags?post=6719"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}